Correlation Between Guardant Health and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guardant Health and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guardant Health and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guardant Health and Myriad Genetics, you can compare the effects of market volatilities on Guardant Health and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guardant Health with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guardant Health and Myriad Genetics.

Diversification Opportunities for Guardant Health and Myriad Genetics

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Guardant and Myriad is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Guardant Health and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Guardant Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guardant Health are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Guardant Health i.e., Guardant Health and Myriad Genetics go up and down completely randomly.

Pair Corralation between Guardant Health and Myriad Genetics

Allowing for the 90-day total investment horizon Guardant Health is expected to generate 1.39 times more return on investment than Myriad Genetics. However, Guardant Health is 1.39 times more volatile than Myriad Genetics. It trades about 0.15 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.15 per unit of risk. If you would invest  3,054  in Guardant Health on December 29, 2024 and sell it today you would earn a total of  1,461  from holding Guardant Health or generate 47.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Guardant Health  vs.  Myriad Genetics

 Performance 
       Timeline  
Guardant Health 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Guardant Health are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Guardant Health demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Myriad Genetics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Guardant Health and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guardant Health and Myriad Genetics

The main advantage of trading using opposite Guardant Health and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guardant Health position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind Guardant Health and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities